Everything below concerns reversed-phase HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (with DAC) | ~3647 Da | Calculated from the full amino acid sequence |
| Molecular weight (without DAC) | ~3368 Da | Mod GRF(1-29) variant |
| Appearance | White lyophilized powder | Typical form supplied for research |
| Solubility | Soluble in water | Dissolves in aqueous buffers |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
=== Symmetrical flow === Of these techniques flow FFF was the first to be offered commercially. Flow FFF separates particles based on size, independent of density and can measure macromolecules in the range of 1 nm to 1 μm. In this respect it is the most versatile FFF sub-technique available. The cross flow in Flow FFF enters through a porous frit at the top of the channel, exiting through a semi-permeable membrane outlet frit on the accumulation wall (i.e. the bottom wall). Symmetrical flow has been replaced by asymmetrical flow in the last two decades.
== Clinical significance == There is a rare pathology known as edema of Wharton’s jelly. Its causes have not been established. In some cases, the development of edema is associated with fetal hydrops. In addition, edema may occur in cases of umbilical cord hemangiomas. In such cases, the risk of compression of the umbilical cord vessels increases, which may lead to impaired blood supply to the fetus. Wharton’s jelly edema is usually detected in the second half of pregnancy. The edema may involve the entire umbilical cord or only certain segments of it. In addition to edema, pathologies of Wharton’s jelly include mucoid degeneration accompanied by the formation of pseudocysts, as well as underdevelopment and constriction (coarctation) of the umbilical cord. A 2015 study showed that transplantation of Wharton’s jelly tissue may be considered as a strategy for the treatment of traumatic brain injury.
RNH2 + [CH3SC(NH2)2]+X− → [RN(H)C(NH2)2]+X− + CH3SH The resulting guanidinium ions can often be deprotonated to give the guanidine. This approach is sometimes called the Rathke synthesis, in honor of its discoverer Bernhard Rathke.
The traditions of British centenarians receiving greetings and congratulations was established by King Edward VII in 1908. The famous acrobat and tightrope walker Henry Johnson received a congratulatory letter from Edward VII via his royal courtier Viscount Knollys in 1906. The tradition of royal congratulations continued in 1908, when the secretary for King Edward VII sent a congratulatory letter to Reverend Thomas Lord of Horncastle, Lincolnshire, in a newspaper clipping, declaring, "I am commanded by the King to congratulate you on the attainment of your hundredth year, after a most useful life." The practice was formalised from 1917, under the reign of King George V, who also sent congratulations then sent by a telegram on the attainment of a diamond wedding anniversary (or jubilee) marking 60 years of marriage. During the reign of King George V, only 24 telegrams were sent; however, with the aging population, this increased to 273 during 1952, when Queen Elizabeth II ascended the throne. The Queen also sent a telegram, and later a portrait-style greeting card with the notation, "I am so pleased to know that you are celebrating your one hundredth birthday. I send my congratulations and best wishes to you on such a special occasion." Each few years the card was updated with a current updated picture of the Queen to ensure people did not receive the same card more than once. The Queen further sent her congratulations on one's 105th birthday and every year thereafter as well as on special wedding anniversaries.
Sources: en.wikipedia.org
With the new knowledge about the role of PCSK9 and its location in the genome, they sequenced the relevant region of chromosome 1 in people with very low cholesterol and they found nonsense mutations in the gene, thus validating PCSK9 as a biological target for drug discovery. In July 2015, the FDA approved the first PCSK9 Inhibitor drugs for medical use.
==== By activase ==== The removal of the inhibitory RuBP, CA1P, and the other inhibitory substrate analogs by activase requires the consumption of ATP. This reaction is inhibited by the presence of ADP, and, thus, activase activity depends on the ratio of these compounds in the chloroplast stroma. Furthermore, in most plants, the sensitivity of activase to the ratio of ATP/ADP is modified by the stromal reduction/oxidation (redox) state through another small regulatory protein, thioredoxin. In this manner, the activity of activase and the activation state of RuBisCO can be modulated in response to light intensity and, thus, the rate of formation of the ribulose 1,5-bisphosphate substrate.
Through additional reactions the nitrogen is incorporated into glutamine and glutamate and eventually used in the synthesis of other amino acids and nitrogenous compounds. After harvest, the majority (around 80%) of available nitrogenous compounds found in the grapes are concentrated in the skins and seeds. These compounds get released into the must during the process of crushing and during maceration/skin contact. Even after pressing up to 80% of initial nitrogen content within each grape berry will be left behind in the pomace.
Sources: en.wikipedia.org
1H, the most commonly used spin-1/2 nucleus in NMR investigations, has been studied using many forms of NMR. Hydrogen is highly abundant, especially in biological systems. It is the nucleus providing the strongest NMR signal (apart from 3H, which is not commonly used due to its instability and radioactivity). Proton NMR has a narrow chemical-shift range but gives sharp signals in solution state. Fast acquisition of quantitative spectra (with peak integrals in stoichiometric ratios) is possible due to short relaxation time. The 1H nucleus has provided the sole diagnostic signal for clinical magnetic resonance imaging (MRI). 2H, a spin-1 nucleus, is commonly utilized to provide a signal-free medium in the form of deuterated solvents for proton NMR, to avoid signal interference from hydrogen-containing solvents in measurement of 1H NMR of solutes. It is also used in determining the behavior of lipids in lipid membranes and other solids or liquid crystals as it is a relatively non-perturbing label which can selectively replace 1H. Alternatively, 2H can be detected in media specially labeled with 2H. Deuterium resonance is commonly used in high-resolution NMR spectroscopy to monitor drift of the magnetic field strength (lock) and to monitor the homogeneity of the external magnetic field. 3He is very sensitive to NMR. It exists at a very low concentration in natural helium and can be purified from 4He. It is used mainly in studies of endohedral fullerenes, where its chemical inertness is beneficial to ascertaining the structure of the entrapping fullerene.
== Behaviour == The coastal taipan is primarily diurnal, being mostly active in the early to midmorning period, although it may become nocturnal in hot weather conditions. The consensus of snake handlers is that the coastal taipan tends to avoid confrontation, but becomes highly defensive if provoked.
Guests on the album included former bandmate Mick Jones, Saxa, Pato Banton, and Chris Spedding; ex-band members Horace Panter and Stoker also participated in the album's creation, co-writing one song apiece. (Stoker also received an "additional recording" credit.) The single "Rainy Days" met with limited success in the US, but fared better in some international markets, notably Brazil. Sales were less than earlier albums, however, and Roger became tired of traveling to America, and they soon broke up again. Since 2004, Dave Wakeling has toured the US with a full backing band as the English Beat. They often perform General Public tracks. "Ranking" Roger Charlery died at his home in Birmingham on 26 March 2019 at the age of 56.
One weakness of these measures is that they are not good indicators of liver vitamin A stores as retinyl esters in hepatic stellate cells. The amount of vitamin A leaving the liver, bound to retinol binding protein (RBP), is under tight control as long as there are sufficient liver reserves. Only when liver content of vitamin A drops below approximately 20 μg/gram will concentration in the blood decline.
Sources: en.wikipedia.org
The synthetic peptide keeps the receptor-binding region of GHRH but carries substitutions that resist enzymatic cleavage. In the DAC version, an added group also anchors the molecule to albumin, extending its presence in the bloodstream.
The maleimide group forms a covalent link with albumin, an abundant blood protein. This attachment slows clearance, so a single administration persists much longer than the unmodified peptide. The feature is the main reason the two variants are handled differently in study design.
It is not an approved therapeutic product in major regulatory jurisdictions. It appears in research chemical catalogs and scientific literature rather than pharmacy shelves. Clinical development was limited and did not reach approval.
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.